Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• Sabra Healthcare REIT, Inc. has received an average recommendation of "Moderate Buy" from nine brokerages, with a twelve-month price target averaging $20.71.
• The company recently reported quarterly earnings per share (EPS) of $0.38, which surpassed analysts' expectations of $0.36, along with a revenue of $189.15 million, marking a 7.4% increase year-over-year.
• Sabra Healthcare REIT declared a quarterly dividend of $0.30 per share, contributing to an annualized yield of 6.7%, despite a high dividend payout ratio of 157.89%.

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine research firms that are currently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $20.7143.

Several equities analysts have issued reports on the company. Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Scotiabank boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. BMO Capital Markets boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday, August 25th. Cantor Fitzgerald began coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They set a "neutral" rating and a $20.00 target price on the stock. Finally, JMP Securities upped their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in SBRA. SVB Wealth LLC acquired a new position in shares of Sabra Healthcare REIT during the first quarter worth approximately $34,000. UMB Bank n.a. raised its holdings in Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after buying an additional 1,621 shares during the last quarter. Wealth Preservation Advisors LLC acquired a new position in Sabra Healthcare REIT during the first quarter worth $38,000. EverSource Wealth Advisors LLC raised its holdings in Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust's stock worth $47,000 after buying an additional 1,536 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in Sabra Healthcare REIT by 61.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock worth $49,000 after buying an additional 1,065 shares during the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Price Performance

SBRA stock opened at $17.88 on Friday. The firm has a market cap of $4.29 billion, a price-to-earnings ratio of 23.53, a PEG ratio of 1.21 and a beta of 0.85. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT has a 12-month low of $15.60 and a 12-month high of $20.03. The company's fifty day simple moving average is $18.77 and its 200 day simple moving average is $18.16.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm's revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, analysts expect that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.7%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is 157.89%.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.